BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2544917)

  • 1. Increased 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disorders.
    Pandey GN; Janicak PG; Javaid JI; Davis JM
    Psychiatry Res; 1989 Apr; 28(1):73-88. PubMed ID: 2544917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.
    Takeda T; Harada T; Otsuki S
    Biol Psychiatry; 1989 May; 26(1):52-60. PubMed ID: 2541808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
    Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
    J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet alpha 2-adrenergic receptor sensitivity in major depressive disorder.
    Stahl SM; Lemoine PM; Ciaranello RD; Berger PA
    Psychiatry Res; 1983 Nov; 10(3):157-64. PubMed ID: 6320244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet alpha-2-adrenergic dysfunction in negative symptom schizophrenia: a preliminary study.
    Rosen J; Silk KR; Rice HE; Smith CB
    Biol Psychiatry; 1985 May; 20(5):539-45. PubMed ID: 2985130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs.
    GarcĂ­a-Sevilla JA; Hollingsworth PJ; Smnith CB
    Eur J Pharmacol; 1981 Sep; 74(4):329-41. PubMed ID: 6271559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet alpha 2-adrenergic receptors in depressed patients and healthy volunteers: the effects of desipramine.
    Werstiuk ES; Auffarth SE; Coote M; Gupta RN; Steiner M
    Pharmacopsychiatry; 1992 Jul; 25(4):199-206. PubMed ID: 1326772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between membrane fluidity and adrenoceptor binding in depression.
    Piletz JE; Sarasua M; Chotani M; Saran A; Halaris A
    Psychiatry Res; 1991 Jul; 38(1):1-12. PubMed ID: 1682966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
    Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
    Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super high affinity 3H-para-aminoclonidine binding to platelet adrenoceptors in depression.
    Piletz JE; Halaris A
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):541-53. PubMed ID: 2900540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet membrane alpha 2-adrenergic receptors in depression.
    Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
    Psychiatry Res; 1992 Sep; 43(3):243-52. PubMed ID: 1359596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patients.
    Georgotas A; Schweitzer J; McCue RE; Armour M; Friedhoff AJ
    Life Sci; 1987 Jun; 40(22):2137-43. PubMed ID: 3035303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tritiated imipramine binding sites in affective disorders and schizophrenia. Influence of circannual variation.
    Desmedt DH; Egrise D; Mendlewicz J
    J Affect Disord; 1987; 12(3):193-8. PubMed ID: 2440932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment.
    Pandey GN; Pandey SC; Ren X; Dwivedi Y; Janicak PG
    Psychopharmacology (Berl); 2003 Nov; 170(2):115-23. PubMed ID: 12845409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
    Jeanningros R; Gronier B; Azorin JM; Tissot R
    Neuropsychobiology; 1989; 22(1):33-40. PubMed ID: 2561683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics.
    Baron M; Barkai A; Gruen R; Peselow E; Fieve RR; Quitkin F
    Am J Psychiatry; 1986 Jun; 143(6):711-7. PubMed ID: 3717391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet serotonin-2 receptor binding sites in depression and suicide.
    Pandey GN; Pandey SC; Janicak PG; Marks RC; Davis JM
    Biol Psychiatry; 1990 Aug; 28(3):215-22. PubMed ID: 2378926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of platelet alpha 2 adrenoceptors and measurement in control and depressed subjects.
    Campbell IC; McKernan RM; Checkley SA; Glass IB; Thompson C; Shur E
    Psychiatry Res; 1985 Jan; 14(1):17-31. PubMed ID: 2986192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients.
    Piletz JE; Halaris A; Saran A; Marler MR
    Arch Gen Psychiatry; 1991 Sep; 48(9):813-20. PubMed ID: 1681792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.